Plastic injection moulding company OGM expands cleanroom facilities in Oxford factory

OGM (Owen Greenings and Mumford Ltd.), a leading plastic injection moulding company, is investing £500,000 to expand its cleanroom facilities at its factory in Oxford, UK. The investment will fund a 25% increase in the cleanroom's footprint, the acquisition of two new machines, and the expansion of the team of cleanroom machine operators with up to six new roles.

The company is expanding its cleanroom to accommodate new contracts and growth from existing customers, specifically in producing plastic injection moulded parts for orthopaedic medical devices and automated surgical equipment. The new investment will enable OGM to run higher cavitation tooling to produce larger components and increase overall cleanroom capacity.

The first stage of the expansion project is set to be completed by May and will include the acquisition of a 100-tonne ARBURG and a 160-tonne KraussMaffei machine. These machines will increase the company's injection moulding capability and provide extra space for value-added processes such as automated assembly within the cleanroom environment.

According to Paul Wightman, group managing director of Owen Greenings & Mumford (Holdings), the expansion plans will increase the company's injection moulding capability and provide extra space for added value processes such as automated assembly within the cleanroom environment.

"This is part of a larger investment programme for OGM Ltd," Wightman said. "Elsewhere in the factory, we have built a mezzanine floor to house ultrasonic cleaning machines that will form part of an automated production cell. Total investment in our Oxford facility will likely exceed £2 million by the end of this year."

OGM, which celebrated its 60th anniversary at the end of last year, is committed to providing high-quality plastic injection moulded parts for various industries, including automotive, medical, and industrial. It is also set to increase its production capacity, create new jobs, and boost its competitiveness in the market. The company's expansion plans demonstrate its commitment to meeting the increasing demand for medical device production and investing in the latest technologies and equipment to ensure the highest quality standards.